Found: 6
Select item for more details and to access through your institution.
The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report).
- Published in:
- Pure & Applied Chemistry, 2018, v. 90, n. 8, p. 1255, doi. 10.1515/pac-2017-0605
- By:
- Publication type:
- Article
Assessment of synthetic cannabinoid FUB‐AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC–MS/MS.
- Published in:
- Biomedical Chromatography, 2020, v. 34, n. 9, p. 1, doi. 10.1002/bmc.4884
- By:
- Publication type:
- Article
Phase I metabolism of synthetic cannabinoid receptor agonist PX‐1 (5F‐APP‐PICA) via incubation with human liver microsomes and UHPLC–HRMS.
- Published in:
- Biomedical Chromatography, 2020, v. 34, n. 3, p. 1, doi. 10.1002/bmc.4786
- By:
- Publication type:
- Article
In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3).
- Published in:
- Journal of Analytical Toxicology, 2020, v. 44, n. 3, p. 226, doi. 10.1093/jat/bkz086
- By:
- Publication type:
- Article
In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB‐CHMINACA via human liver microsome incubation and high‐resolution mass spectrometry.
- Published in:
- Drug Testing & Analysis, 2019, v. 11, n. 8, p. 1264, doi. 10.1002/dta.2615
- By:
- Publication type:
- Article
Metabolic profiling of synthetic cannabinoid 5F‐ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra‐high‐performance liquid chromatography/high‐resolution mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2020, v. 34, n. 22, p. 1, doi. 10.1002/rcm.8908
- By:
- Publication type:
- Article